Arrhythmia Detection After MI
Arrhythmia Detection After Myocardial Infarction Trial
Samir Saba
200 participants
Aug 9, 2022
INTERVENTIONAL
Conditions
Summary
Patients post acute myocardial infarction (AMI) have a high risk of mortality but the use of an implantable defibrillator in the early aftermath of an AMI has not been shown to improve patients' survival. The VEST trial recently demonstrated an improved overall survival in post AMI patients with the use of a wearable defibrillator. The same improvement was not demonstrated for the risk of sudden cardiac death. Monitoring patients after AMI using an implantable cardiac monitor (ICM) may document findings that can impact patient management and eventually improve their outcomes. We are therefore conducting the AID MI trial to examine the impact of ICM on patient management in the post AMI setting.
Eligibility
Inclusion Criteria5
- Adults, age 18 years or older
- AMI (STEMI and NSTEMI)
- Willing to give written informed consent
- Expected discharge from hospital within 7 days of AMI
- Willing to receive ICM insertion within 21 days of index AMI
Exclusion Criteria5
- Existing pacemaker, ICD, ICM, or any other implantable cardiac electronic device
- Pregnant
- Index AMI was more than 21 days
- Unwilling/cannot insert ICM within 21 days post AMI
- Planned ICD implant, planned CABG or any open-heart surgery (e.g. for severe valvular disease)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Routine monitoring of post AMI patient with clinic visits
Implantation of ICM through small incision (2 mm) under the skin
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05073419